Valeant Pharmaceuticals (Dermatology products) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Valeant Pharmaceuticals (Dermatology products) General Information
Description
A portfolio of dermatology products. The dermatology products are primarily utilized for skin care treatment.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- 2150 St. Elzéar Boulevard West
- Laval, Quebec H7L 4A8
- Canada
Valeant Pharmaceuticals (Dermatology products) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Valeant Pharmaceuticals (Dermatology products) Executive Team (1)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Gene Burdette | Director, Surgical Business Unit and Product Management |
Valeant Pharmaceuticals (Dermatology products) Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|